Published 29 février 2016
Created 29 février 2016 Last modified 29 février 2016
No answer selected. Please try again.
Please select either existing option or enter your own, however not both.
Please select minimum {0} answer(s).
Please select maximum {0} answer(s).
/fr/nephrology-resources/nephrology-polls/17-if-tolvaptan-for-adpkd-was-approved-for-use-but-not-deemed-to-be-cost-effective-would-you-still-prescribe-it-to-your-patients?task=poll.vote&format=json
17
radio
1
[{"id":64,"title":"Yes","votes":66,"type":"x","order":1,"pct":61.67999999999999971578290569595992565155029296875,"resources":[]},{"id":65,"title":"No","votes":41,"type":"x","order":2,"pct":38.32000000000000028421709430404007434844970703125,"resources":[]}]
["#ff5b00","#4ac0f2","#b80028","#eef66c","#60bb22","#b96a9a","#62c2cc"]
["rgba(255,91,0,0.7)","rgba(74,192,242,0.7)","rgba(184,0,40,0.7)","rgba(238,246,108,0.7)","rgba(96,187,34,0.7)","rgba(185,106,154,0.7)","rgba(98,194,204,0.7)"]
350
Loading suggestions, please wait...
Loading suggestions, please wait...
Loading suggestions, please wait...
Loading suggestions, please wait...
right